NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. 27 March 2017 Discontinued. NICE was ...
NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. 27 March 2017 Discontinued. NICE was ...
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする
フィードバック